Goodwill and Other Intangible Assets

12 Months Ended

Mar. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Most of the Company's goodwill is related to the Sanuk reportable segment, with the remaining related to the UGG and other brands reportable segments. The Company's goodwill and other intangible assets are summarized as follows:



	3/31/2015		3/31/2014		12/31/2013
Intangibles subject to amortization
Weighted-Average Amortization Period	13 years		14 years		14 years
Gross Carrying Amount	$	109,604	$	101,982	$	101,963
Accumulated Amortization	37,316		26,026		24,140
Net Carrying Amount	72,288		75,956		77,823
Intangibles not subject to amortization
Goodwill	127,934		127,934		128,725
Trademarks	15,455		15,455		15,455
Total goodwill and other intangible assets	$	215,677	$	219,345	$	222,003

Changes in the Company's goodwill are summarized as follows:



	Goodwill, Gross			Accumulated Impairment			Goodwill, Net
Balance at January 1, 2013	$	144,556		$	(15,831	)	$	128,725
Changes related to additions, impairments and other adjustments	—			—			—
Balance at December 31, 2013	144,556			(15,831		)	128,725
Adjustments related to prior acquisitions	(791		)	—			(791		)
Balance at March 31, 2014	143,765			(15,831		)	127,934
Changes related to additions, impairments and other adjustments	—			—			—
Balance at March 31, 2015	$	143,765		$	(15,831	)	$	127,934

As of December 31, 2014 and 2013, the Company performed its annual impairment tests and evaluated its UGG and other brands' goodwill. As of October 31, 2014 and 2013, the Company performed its annual impairment tests and evaluated its Teva trademarks and Sanuk goodwill. Based on the carrying amounts of the UGG, Teva, Sanuk, and other brands' goodwill, trademarks, and net assets, the brands' fiscal year 2015, quarter ended March 31, 2014 and fiscal year 2013 sales and operating results, and the brands' long-term forecasts of sales and operating results as of their evaluation dates, the Company concluded that the carrying amounts of the UGG, Sanuk and other brands' goodwill, as well as the Teva trademarks, were not impaired. The Sanuk brand goodwill was evaluated based on Level 3 inputs as of October 31, 2013 and based on qualitative analyses as of October 31, 2014. As of December 31, 2014 and 2013, and as of October 31, 2014 and 2013, all goodwill other than the Sanuk brand goodwill and all other nonamortizable intangibles were evaluated based on qualitative analyses.

The Company's goodwill by segment is as follows:



	3/31/2015		3/31/2014		12/31/2013
UGG brand	$	6,101	$	6,101	$	6,101
Sanuk brand	113,944		113,944		113,944
Other brands	7,889		7,889		8,680
Total	$	127,934	$	127,934	$	128,725

Aggregate amortization expense for amortizable intangible assets for the year ended March 31, 2015, quarter ended March 31, 2014 and years ended December 31, 2013 and 2012, was $11,291, $1,886, $7,975 and $9,312, respectively. The following table summarizes the expected amortization expense on existing intangible assets, excluding indefinite-lived intangible assets of $8,044 and trademarks of $15,455, for the next five years:



Year ending March 31,
2016	$	9,358
2017	8,361
2018	6,278
2019	5,621
2020	3,813
Thereafter	30,813
	$	64,244

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details